We are live on ! Find out more
CDMO

Avid Bioservices, Inc. Common Stock

Delisted

CDMO was delisted on the 4th of February, 2025.

76 hedge funds and large institutions have $12.1M invested in Avid Bioservices, Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 15 increasing their positions, 24 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

380% more call options, than puts

Call options by funds: $24K | Put options by funds: $5K

10% less funds holding

Funds holding: 8476 (-8)

24% less capital invested

Capital invested by funds: $16M → $12.1M (-$3.88M)

28% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 25

38% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 24

Holders
76
Holders Change
-8
Holders Change %
-9.52%
% of All Funds
2.03%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
18
Increased
15
Reduced
24
Closed
25
Calls
$24K
Puts
$5K
Net Calls
+$19K
Net Calls Change
-$71K
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$3.02M -$177K -63,375 -5%
KCM
2
Kennedy Capital Management
Missouri
$2.77M +$3.03M +1,085,483 New
BIT
3
BlackRock Institutional Trust
California
$1.49M -$764K -274,175 -32%
FIM
4
Freedom Investment Management
Connecticut
$543K +$34.3K +12,291 +6%
Renaissance Technologies
5
Renaissance Technologies
New York
$492K +$38.3K +13,743 +8%
Millennium Management
6
Millennium Management
New York
$410K +$448K +160,820 New
Geode Capital Management
7
Geode Capital Management
Massachusetts
$396K -$121K -43,474 -22%
PP
8
Paloma Partners
Connecticut
$311K +$340K +122,113 New
Jacobs Levy Equity Management
9
Jacobs Levy Equity Management
New Jersey
$308K -$65K -23,314 -16%
LCM
10
Laurion Capital Management
New York
$242K +$264K +94,757 New
BA
11
BlackRock Advisors
Delaware
$187K -$29.1K -10,445 -12%
QI
12
QS Investors
New York
$183K
California Public Employees Retirement System
13
California Public Employees Retirement System
California
$175K
CS
14
Credit Suisse
Switzerland
$159K +$166K +59,559 +2,024%
Commonwealth Equity Services
15
Commonwealth Equity Services
Massachusetts
$153K -$26.2K -9,414 -14%
D.E. Shaw & Co
16
D.E. Shaw & Co
New York
$149K +$96.8K +34,716 +145%
Northern Trust
17
Northern Trust
Illinois
$131K -$747K -268,053 -84%
Goldman Sachs
18
Goldman Sachs
New York
$97K +$55.8K +20,026 +111%
Bank of New York Mellon
19
Bank of New York Mellon
New York
$87K -$201K -72,008 -68%
PA
20
Perceptive Advisors
New York
$81K +$79.6K +28,571 +822%
AQR Capital Management
21
AQR Capital Management
Connecticut
$70K
LP
22
LMR Partners
United Kingdom
$66K +$72.4K +25,992 New
BBI
23
Baxter Bros Inc
Connecticut
$49K +$54K +19,358 New
Ameriprise
24
Ameriprise
Minnesota
$48K -$89.8K -32,234 -63%
Squarepoint
25
Squarepoint
New York
$42K +$46K +16,486 New

CDMO Hedge Fund Activity: Q2 2016 in Review

76 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q2 2016, worth a combined $12.1M — down 24% from $16M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of CDMO and 18 opened new positions — a net loss of 7 holders — while 24 trimmed existing stakes and 15 added.

The largest buyer was Kennedy Capital Management, opening a new position worth an estimated $3.03M. The largest seller was BlackRock Fund Advisors, cutting an estimated $2.32M.

  • 76 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q2 2016, down from 84 in Q1 2016.
  • Funds reported $12.1M of Avid Bioservices, Inc. Common Stock stock for Q2 2016, down 24% quarter-over-quarter.
  • 18 funds opened new Avid Bioservices, Inc. Common Stock positions in Q2 2016 and 25 closed out, a net change of -7 holders.
  • The largest Avid Bioservices, Inc. Common Stock buyer in Q2 2016 was Kennedy Capital Management, an estimated $3.03M added.
  • The largest Avid Bioservices, Inc. Common Stock seller in Q2 2016 was BlackRock Fund Advisors, an estimated $2.32M sold.

Based on aggregated 13F filings for Q2 2016.